Pierre F. Saboret/X
Sep 12, 2026, 16:14
Pierre F. Saboret: IPF and Long Term Prognosis Thrombosis and Haemostasis
Pierre F. Saboret, Member of the Executive Committee for Education at European Atherosclerosis Society, shared a post on X:
“Grateful for this new collaboration with Jupiter Group led by Elad Asher with friends Dan Atar and Mamas A. Mamas.
IPF and long term prognosis Thrombosis and Haemostasis”
Title: Association of Admission Immature Platelet Fraction with Long-Term Mortality Following Primary Percutaneous Coronary Intervention for STEMI
Authors: Elad Asher, Louay Taha, Mohammad Karmi, Pierre Sabouret, Mamas A. Mamas, Dan Atar, Noam Fink, Ari Naimark, Michael Glikson
Stay updated with Hemostasis Today.
-
Oct 28, 2026, 11:55Natalia C. Badillo: Anticoagulation in AF – A Decision Beyond the Score
-
Oct 28, 2026, 08:40Simon Fletcher: The Hidden Burden of Non-Severe Haemophilia
-
Oct 28, 2026, 08:08Paul Agwu: A Low Platelet Count Is Not a Diagnosis – It Is a Clue
-
Oct 28, 2026, 07:54Ifeanyichukwu Ifechidere: When Normal Results Don’t Explain the Bleeding
-
Oct 28, 2026, 06:06Thirunavukkarasu Angappan: Anti-TFPI Antibodies and an Antithrombin-Lowering Drug
-
Oct 28, 2026, 05:52Reegan Burnell-Clarke: Pegcetacoplan and the Evolving Treatment Landscape of PNH
-
Oct 28, 2026, 03:50ZhiChao (David) Yang: MedicalBench Tests AI in Clinical Reasoning
-
Oct 28, 2026, 03:46Phillip Smith: Strengthening Partnerships and Connections in the Rare Disease and Hemophilia Communities
-
Oct 28, 2026, 03:42Ashley Bradley: Understanding Jalen Hurts’ Diagnosis: DVT and Venous Thromboembolism in Athletes